XML 17 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
TOTAL REVENUE $ 8,753 $ 6,427 $ 24,838 $ 17,747
COST OF GOODS SOLD [1] (4,087) (4,733) (10,121) (9,498)
RESEARCH AND DEVELOPMENT EXPENSES [2] (7,579) (7,689) (16,346) (14,811)
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES [3] (2,611) (3,171) (5,765) (6,309)
OPERATING LOSS (5,524) (9,166) (7,394) (12,871)
FINANCIAL EXPENSES (623) (2,203) (1,242) (4,240)
FINANCIAL INCOME 813 128 1,016 344
FINANCIAL INCOME (EXPENSES) - NET 190 (2,075) (226) (3,896)
OTHER INCOME       51
NET LOSS FOR THE PERIOD $ (5,334) $ (11,241) $ (7,620) $ (16,716)
LOSS PER SHARE OF COMMON STOCK - BASIC $ (0.11) $ (0.25) $ (0.16) $ (0.39)
LOSS PER SHARE OF COMMON STOCK - DILUTED $ (0.11) $ (0.25) $ (0.16) $ (0.39)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE - BASIC 47,327,952 45,436,907 46,589,976 42,744,426
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE - DILUTED 47,327,952 45,436,907 46,589,976 42,744,426
Goods        
TOTAL REVENUE $ 3,382 $ 3,243 $ 12,410 $ 7,754
License and R&D Services        
TOTAL REVENUE $ 5,371 $ 3,184 $ 12,428 $ 9,993
[1] (1) Includes share-based compensation
[2] (2) Includes share-based compensation
[3] (3) Includes share-based compensation